BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chelliah SS, Paul EAL, Kamarudin MNA, Parhar I. Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas. Molecules 2021;26:1169. [PMID: 33671796 DOI: 10.3390/molecules26041169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Yue P, Peng Y, Sun Y, Chen X, Zhao Z, Han B. Recent advances in drug delivery systems for targeting brain tumors. Drug Deliv 2023;30:1-18. [PMID: 36597214 DOI: 10.1080/10717544.2022.2154409] [Reference Citation Analysis]
2 Zhou J, Li L, Jia M, Liao Q, Peng G, Luo G, Zhou Y. Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions. Cancer Medicine 2022. [DOI: 10.1002/cam4.5511] [Reference Citation Analysis]
3 Rodríguez-camacho A, Flores-vázquez JG, Moscardini-martelli J, Torres-ríos JA, Olmos-guzmán A, Ortiz-arce CS, Cid-sánchez DR, Pérez SR, Macías-gonzález MDS, Hernández-sánchez LC, Heredia-gutiérrez JC, Contreras-palafox GA, Suárez-campos JDJE, Celis-lópez MÁ, Gutiérrez-aceves GA, Moreno-jiménez S. Glioblastoma Treatment: State-of-the-Art and Future Perspectives. IJMS 2022;23:7207. [DOI: 10.3390/ijms23137207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Liu Y, Chen Z, Li A, Liu R, Yang H, Xia X. The Phytochemical Potential for Brain Disease Therapy and the Possible Nanodelivery Solutions for Brain Access. Front Oncol 2022;12:936054. [DOI: 10.3389/fonc.2022.936054] [Reference Citation Analysis]
5 Senturk F, Cakmak S, Gumusderelioglu M, Ozturk GG. Hydrolytic instability and low-loading levels of temozolomide to magnetic PLGA nanoparticles remain challenging against glioblastoma therapy. Journal of Drug Delivery Science and Technology 2022;68:103101. [DOI: 10.1016/j.jddst.2022.103101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Frosina G. Radiotherapy of High-Grade Gliomas: First Half of 2021 Update with Special Reference to Radiosensitization Studies. Int J Mol Sci 2021;22:8942. [PMID: 34445646 DOI: 10.3390/ijms22168942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]